COOCOOPER COMPANIES, INC.
Ophthalmic Goods
- Revenue
- $4.1B
- 5.1% YoY
- Operating margin
- 16.7%
- 7.9% YoY
- EBITDA
- $1.1B
- 1.9% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 2.3×
- $2.4B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear212% of net incomeCash flow under 80% of net income
- Dilutive SBCClear2% of revenueOver 10% of revenue
- Payouts exceed cash flowClear36% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear31% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $3.3B | $3.6B | $3.9B | $4.1B | 5.1% |
| Operating income | $506M | $508M | $533M | $706M | $683M | 3.2% |
| Net income | $2.9B | $386M | $294M | $392M | $375M | 4.4% |
| Operating cash flow | $739M | $692M | $608M | $709M | $796M | 12% |
| Capex | $214M | $242M | $393M | $421M | $362M | 14% |
| Stock-based comp | $44M | $54M | $62M | $75M | $71M | 6.1% |
| Buybacks | $25M | $79M | $0 | $0 | $290M | |
| Dividends | $3M | $3M | $3M | $0 | $0 |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $2M · 5
- Open-market sells, 12 mo
- $0 · 0
- Net
- $2M
Pay vs performance
No pay-versus-performance disclosure yet.